JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Right arrow Help viewing high resolution images
Right arrow Return to article
Click on image to view larger version.


Figure 2


FIGURE 2.  Kaplan–Meier survival curves of NSCLC patients with bone marrow hypermetabolism (BM SUV > 1.7) on 18F-FDG PET vs. patients with normal bone marrow metabolism. BM SUV is normalized for lean body mass (lbm). Median survival of patients with bone marrow hypermetabolism was significantly shorter than that of NSCLC patients with normal bone marrow metabolism (151 vs. 799 d; P = 0.00006, log-rank test). BM = bone marrow.





Right arrow Return to article

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE